Nova Southeastern University; College of Optometry
Fort Lauderdale, Florida, 33328, United States
NCT Number: NCT02086890
Measures of vision in RP patients receiving promising therapy using transcorneal electrical stimulation.
This study is active but is not currently recruiting participants.
18 year and older
All sexes
Interventional
Not applicable
Fort Lauderdale, Florida, 33328, United States
Retinitis pigmentosa (RP) is a slowly progressive retinal degeneration for which there is no proven treatment. Patients are interested in trying alternative therapies to try to reduce their vision loss, but only limited research evidence exists to support their use and potential benefit. The goal of this research project is to gain a better understanding of possible changes in ocular and retinal blood flow and measures of vision in RP patients receiving two promising therapies, electroacupuncture and transcorneal electrical stimulation. We are currently only doing transcorneal electrical stimulation.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation
Using Haig-Streit Octopus perimeter
Time frame: twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation
Using Pelli-Robson visual acuity charts
Time frame: twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation
Using Optical Coherence Tomography
Time frame: twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation
Using Adaptive Sensory Technology Quick CSF
Time frame: twice at baseline, then 2 weeks, 6 weeks and 12 weeks post-intervention initiation
Using the AdaptDx by Maculogix
Nova Southeastern University
Other
Modulating Ocular/Retinal Blood Flow and Visual Function in Retinitis Pigmentosa
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06912633
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT03944239
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05926583
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases
Meguro-ku, Japan
View Trial DetailsNCT05537220
Abnormalities, Multiple, Blindness
Davis, California, United States
View Trial Details